Format

Send to:

Choose Destination
See comment in PubMed Commons below
Toxicol In Vitro. 2013 Mar;27(2):721-30. doi: 10.1016/j.tiv.2012.11.017. Epub 2012 Dec 7.

Toxicological analysis of limonene reaction products using an in vitro exposure system.

Author information

  • 1Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, United States. sanderson4@cdc.gov

Abstract

Epidemiological investigations suggest a link between exposure to indoor air chemicals and adverse health effects. Consumer products contain reactive chemicals which can form secondary pollutants which may contribute to these effects. The reaction of limonene and ozone is a well characterized example of this type of indoor air chemistry. The studies described here characterize an in vitro model using an epithelial cell line (A549) or differentiated epithelial tissue (MucilAir™). The model is used to investigate adverse effects following exposure to combinations of limonene and ozone. In A549 cells, exposure to both the parent compounds and reaction products resulted in alterations in inflammatory cytokine production. A one hour exposure to limonene+ozone resulted in decreased proliferation when compared to cells exposed to limonene alone. Repeated dose exposures of limonene or limonene+ozone were conducted on MucilAir™ tissue. No change in proliferation was observed but increases in cytokine production were observed for both the parent compounds and reaction products. Factors such as exposure duration, chemical concentration, and sampling time point were identified to influence result outcome. These findings suggest that exposure to reaction products may produce more severe effects compared to the parent compound.

Published by Elsevier Ltd.

PMID:
23220291
[PubMed - indexed for MEDLINE]
PMCID:
PMC4680979
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk